Regulatory guidance documents provide recommendations and frameworks to ensure the safety, efficacy, and quality of cancer therapies and diagnostics. They are issued by regulatory agencies such as the FDA, the EMA, and other international bodies to guide researchers, clinicians, and pharmaceutical companies through the complex processes of drug development and approval.
